进一步统计，近3个月内该股累计发生2笔大宗交易，合计成交金额为1889.28万元。该股近5个交易日累 计下跌5.59%，主力资金合计净流出1723.93万元。 责任编辑：小浪快报 第1笔成交价格为25.60元，成交31.00万股，成交金额793.60万元，溢价率为-19.42%，买方营业部为中 国银河证券股份有限公司台州银座北街证券营业部，卖方营业部为中国银河证券股份有限公司佛山绿景 一路证券营业部。 第2笔成交价格为25.60元，成交42.80万股，成交金额1,095.68万元，溢价率为-19.42%，买方营业部为上 海证券有限责任公司温州乐清伯乐东路证券营业部，卖方营业部为中国银河证券股份有限公司佛山绿景 一路证券营业部。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 12月18日，禾川科技收跌0.69%，收盘价为31.77元，发生2笔大宗交易，合计成交量73.8万股，成交金 额1889.28万元。 ...

证券日报网讯 12月15日晚间，禾川科技发布公告称，公司于2025年12月15日召开第五届董事会第十六 次会议，会议审议通过了《关于选举代表公司执行公司事务的董事的议案》《关于确认审计委员会成员 及召集人的议案》，公司董事会选举董事长王项彬先生为代表公司执行公司事务的董事；公司第五届董 事会审计委员会成员仍由何新荣先生、陈志平先生、王项彬先生组成，其中何新荣先生为审计委员会召 集人。 （文章来源：证券日报） ...

证券代码：688320 证券简称：禾川科技 公告编号：2025-064 浙江禾川科技股份有限公司 关于选举代表公司执行公司事务的董事、确认董事会审计委 员会成员及召集人的公告 2025 年 12 月 16 日 1 附件： 浙江禾川科技股份有限公司（以下简称"公司"）于 2025 年 12 月 15 日召开 第五届董事会第十六次会议，会议审议通过了《关于选举代表公司执行公司事务 的董事的议案》《关于确认审计委员会成员及召集人的议案》。现将相关情况公 告如下： 一、 关于选举代表公司执行公司事务的董事的情况 为规范公司治理，根据《公司法》《公司章程》等有关规定，公司董事会选 举董事长王项彬先生（简历见附件）为代表公司执行公司事务的董事，任期自本 次董事会审议通过之日起至公司第五届董事会任期届满日止。根据《公司章程》 的相关规定，代表公司执行公司事务的董事为公司法定代表人。本次选举后，公 司法定代表人未发生变更。 二、 关于确认董事会审计委员会成员及召集人的情况 因公司治理结构调整，董事会审计委员会职权范围发生变化，公司对第五届 董事会审计委员会成员及召集人进行确认。公司第五届董事会审计委员会成员仍 由何新荣先生、 ...

Group 1 - The core viewpoint of the news highlights the strong performance of the robot ETF (562500), which is showing a "V" shaped recovery despite a slight decline of 0.21%, indicating strong bullish resistance [1] - Notable stocks within the ETF include Boke Co., which surged over 8%, and Hechuan Technology, which rose over 4%, while stocks like Gogo Technology and Haimeixing faced short-term pressure [1] - The liquidity in the market is impressive, with a trading volume exceeding 3.32 billion yuan within the first half hour of trading, indicating robust market activity [1] Group 2 - The robot ETF (562500) is the only robot-themed ETF in the market with a scale exceeding 20 billion yuan, covering various segments such as humanoid robots, industrial robots, and service robots, facilitating investors' access to the entire robot industry chain [2] - According to CITIC Securities, the performance of the humanoid robot index is primarily influenced by the progress of the T-chain, including performance iteration, hardware finalization, and mass production guidance [1] - Although the Gen3 hardware finalization and large-scale production have been postponed to 2026, the sector still exhibits resilience [1]

Group 1: Industrial Mother Machine Sector - The industrial mother machine sector shows a positive trend with a total index increase of 1.29% to 1754.21 [2] - Key stocks in this sector include: - GuoJi Heavy Industry (601399) with a price of 4.63, up by 9.98% and 42.46% over the past five days [2] - China First Heavy Industries (601106) at 3.42, also up by 9.97% and 13.62% over the last five days [2] - Weihong Co., Ltd. (300508) at 38.12, increasing by 9.29% and 10.05% in five days [2] - Other notable performers include: - Yuhuan CNC (002903) at 24.54, up by 6.70% [2] - Ruineng Technology (603933) at 30.40, with a 5.89% increase [2] Group 2: Brain-Computer Interface Sector - The brain-computer interface sector experienced significant activity, highlighted by the upcoming "Brain Link World, Intelligence Gathering in Shanghai" conference scheduled for December 4-5, 2025 [3] - Key stocks in this sector include: - Dineike (300884) with a price of 16.82, up by 14.34% and 18.09% over the past five days [3] - Nanjing Panda (600775) at 12.55, increasing by 9.99% and 13.78% [3] - Chengyitong (300430) at 18.99, up by 3.94% [3] - Other stocks showing positive movement include: - Beiyikang (920199) at 34.70, up by 3.89% [3] - Innovation Medical (002173) at 22.29, with a 3.05% increase [3]

Core Viewpoint - The company is positioned in the upstream segment of the photovoltaic industry, primarily serving equipment manufacturers, and is experiencing a challenging environment with low order volumes despite ongoing industry efforts to mitigate internal competition [1] Group 1: Photovoltaic Industry - The photovoltaic industry is currently pushing against internal competition, which mainly benefits downstream component manufacturers [1] - The company's performance improvement is minimally impacted by the positive developments in the downstream sector [1] - Photovoltaic orders remain at a low point within the industry [1] Group 2: Lithium Battery Industry - The company is actively expanding its presence in the lithium battery sector, resulting in a year-on-year increase in lithium battery orders [1]

Core Viewpoint - The company, Hechuan Technology, maintains a high level of R&D investment, with R&D expenses amounting to 93 million yuan, representing 12.69% of its operating revenue for the first three quarters of 2025 [1] Group 1 - The company has independently designed and developed industrial control chips that integrate main control MCU, motion control algorithms, storage, and industrial real-time Ethernet technology [1] - The industrial control chips have already entered mass production [1] - Currently, the company has no plans to develop AI chips [1]

Group 1 - The core event on November 24 marks a significant "super meeting day" for multiple listed companies in Zhejiang, indicating a collective strategic decision-making process [1][3][4][5] - Companies like Huawai Technology, Anglikang, and Hechuan Technology are holding shareholder meetings to discuss future strategies and governance [1][6] Group 2 - There is a noticeable performance divergence among Zhejiang-listed companies, with Zhejiang Rongtai reporting a revenue of 960 million yuan for Q1-Q3 2025, a year-on-year increase of 18.65%, and a net profit of 203 million yuan, up 22.04% [7][8] - In contrast, Zhejiang Natural reported a revenue decline of 30.38% and a net profit drop of 40.63% for the same period [7][8] Group 3 - Emerging sectors are seeing accelerated investments, with Zhejiang Rongtai focusing on humanoid robot components, which are expected to experience significant growth [9][10] - The company is also involved in the new energy sector, with its mica products being crucial for electric vehicle battery safety, anticipating increased demand due to upcoming regulations [10] Group 4 - Institutional investors are showing strong interest in Zhejiang companies, with Zhejiang Rongtai projected to achieve revenues of 1.423 billion, 2.481 billion, and 4.178 billion yuan from 2025 to 2027, alongside net profits of 277 million, 485 million, and 839 million yuan respectively [11][12] - Zhejiang Pharmaceutical has also attracted attention, with forecasts estimating a net profit of 1.113 billion yuan for 2025 [13] Group 5 - Strategic upgrades are underway among Zhejiang-listed companies, focusing on optimizing corporate governance structures, as seen with Anglikang's adjustments to its supervisory framework [15] - International expansion is being pursued, with Zhejiang Rongtai establishing a production base in Thailand and Zhejiang Natural having subsidiaries in Vietnam and Cambodia [15][16] - Continuous investment in technological innovation is emphasized, with companies like Zhejiang Rongtai and Zhejiang Zhenyuan enhancing their R&D capabilities [16]

Group 1 - The core point of the news is that Hechuan Technology (688320.SH) announced a share reduction plan by its major shareholders and executives due to personal funding needs [2][3] - Major shareholder and Vice General Manager Xiang Henghui plans to reduce his holdings by up to approximately 2.7289 million shares, representing 1.8071% of the total share capital and 25% of his total holdings [2] - General Manager Xu Xiaojie intends to reduce his holdings by up to approximately 1.1465 million shares, which is 0.7592% of the total share capital and also 25% of his total holdings [2] - Vice General Manager Yan Pengfei plans to reduce his holdings by up to 655,100 shares, accounting for 0.4338% of the total share capital and 25% of his total holdings [2] Group 2 - In addition to the executives, several entities associated with the actual controller of Hechuan Technology plan to reduce their holdings by a total of up to approximately 4.5304 million shares, which is 3% of the total share capital [3] - The shares being reduced by these shareholders and executives were originally held prior to the company's initial public offering, with some shares having been released from restrictions and listed for trading on October 28 of this year [3] - It is noteworthy that the company's controlling shareholder and actual controller, Chairman Wang Xiangbin, will not participate in this share reduction plan [3]

Group 1 - Kanglongda's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 4.83 million shares [1] - The company specializes in the research, production, and sales of special and ordinary labor protection gloves [1] Group 2 - Haizheng Pharmaceutical's subsidiary plans to collaborate with East China Institute on a biological method for synthesizing heparin, with a project contract amount not exceeding 120 million yuan [2] - The company focuses on the research, production, and sales of chemical raw materials and formulations [3] Group 3 - Tianyin Holdings received approval from the China Securities Regulatory Commission for a stock issuance to specific investors [4] - The company is engaged in the sales of smart terminals, e-commerce, lottery, mobile resale, and mobile internet businesses [4] Group 4 - Shanghai Yashi plans to use up to 200 million yuan of temporarily idle raised funds for cash management in high-security, liquid deposit products [5] - The company specializes in supply chain logistics and execution trade [6] Group 5 - Parker New Materials intends to use 130 million yuan of idle raised funds to purchase structured deposits with expected annual yields between 0.59% and 2.9001% [7] - The company focuses on the research, production, and sales of various types of ring forgings, free forgings, and die forgings [7] Group 6 - Huayang New Materials appointed Jing Hongsheng as the new general manager [8] Group 7 - Liyuan Technology's shareholder plans to reduce holdings by up to 2.03% of the company's shares, totaling no more than 3.04 million shares [9] - The company specializes in the research, design, and integration of environmental water treatment systems and hydrogen fuel cell engine systems [9] Group 8 - Shengnuo Biopharmaceutical's subsidiary received approval for the listing application of Visepegenatide raw materials, a GLP-1 receptor agonist for treating type 2 diabetes and obesity [10][11] - The company focuses on the research, production, and sales of peptide raw materials and formulations [10] Group 9 - Puluo Pharmaceutical plans to repurchase shares worth between 180 million and 360 million yuan, with a maximum price of 23 yuan per share [12] - The company specializes in the research, production, and sales of raw material intermediates and innovative drugs [12] Group 10 - Dongfang Electric's subsidiary plans to establish a joint venture with Anhui Waneng Energy, with a registered capital of approximately 1.857 billion yuan [13] - The company is involved in the development, design, manufacturing, and sales of advanced power generation equipment [13] Group 11 - Hefei China announced that its stock will resume trading on November 20 after completing a review of abnormal trading fluctuations [14] - The company focuses on international trade and after-sales services related to in vitro diagnostic medical devices [14] Group 12 - Dafeng Industrial won a bid for the stage equipment project of the Shenzhen International Performing Arts Center, with a contract amount of 165 million yuan [15] - The company specializes in cultural sports equipment, digital art technology, and operation services [15] Group 13 - Baiyunshan's subsidiary received a drug registration certificate for An Gong Niu Huang Wan in Vietnam [16] - The company is engaged in the research, manufacturing, and sales of traditional Chinese and Western medicines [16] Group 14 - Neusoft Group received a notification to supply intelligent cockpit domain controllers for multiple models from a well-known domestic automobile manufacturer, with an estimated total amount of about 4.2 billion yuan [17] - The company focuses on providing industry solutions and software products [17] Group 15 - Huayu Pharmaceutical's product received overseas marketing approval [18] - The company specializes in the research, production, and sales of innovative and high-quality generic drugs in the oncology field [18] Group 16 - Yao Pi Glass received approval from the CSRC for its stock issuance to specific investors [19] - The company specializes in the production and sales of float glass and processed glass [19] Group 17 - Guangyu Yuan's vice president Wang Junbo resigned due to work adjustments [20] - The company focuses on the production and sales of traditional Chinese medicine products [20] Group 18 - Biyi Co. received approval from the CSRC for its stock issuance to specific investors [21] - The company specializes in the design, manufacturing, and sales of smart small household appliances [21] Group 19 - Sunshine Nuohe's application for acquiring 100% equity of Jiangsu Langyan Life Science Technology Co., Ltd. through share issuance and convertible bonds has been accepted by the Shanghai Stock Exchange [22] - The company provides comprehensive drug research and development services for domestic pharmaceutical enterprises and research institutions [22] Group 20 - Longxin General plans to increase capital in its wholly-owned subsidiary by no more than 1.65 billion yuan [23] - The company specializes in the research, production, and sales of motorcycles and engines [23] Group 21 - Jiekang Equipment received a corrective order from the Tianjin Securities Regulatory Bureau due to internal control deficiencies [24] - The company specializes in the research, production, and sales of nuclear biochemical safety equipment [24] Group 22 - Wantong Technology plans to raise no more than 920 million yuan through a private placement to supplement working capital [25] - The company focuses on information technology services for highways and ports [25] Group 23 - Dongshan Precision has submitted an application for H-share listing to the Hong Kong Stock Exchange [26] - The company specializes in the research, production, and sales of electronic circuit products and precision components [26] Group 24 - Yonghe Intelligent Control plans to publicly transfer 100% equity of its wholly-owned subsidiary Kunming Medical Oncology Hospital [27] - The company specializes in water and heating valve fittings, tumor precision radiation therapy, and photovoltaic battery businesses [27] Group 25 - Aok Shares signed a strategic cooperation framework agreement with Suzhou Qitian New Materials Co., Ltd. [28] - The company focuses on the research and production of high-end new materials derived from ethylene oxide and ethylene [28] Group 26 - Hongquan Technology's shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 299,440 shares [29] - The company specializes in the research, production, and sales of intelligent connected products and software platform development [29] Group 27 - Shilong Industrial's controlling shareholder plans to reduce holdings by up to 3% of the company's shares, totaling no more than 7.2 million shares [30] - The company specializes in the research, production, and sales of chemical products [30] Group 28 - Tangrenshen decided to terminate the investment in the "Dongchong Phase III Pig Breeding Base Construction Project," reallocating the remaining funds of 78.9587 million yuan to supplement working capital [31] - The company specializes in the research, production, and sales of feed, pigs, meat products, and animal health products [31] Group 29 - Gaode Infrared's actual controller plans to reduce holdings by up to 3% of the company's shares, totaling no more than 12.8 million shares [32] - The company specializes in infrared focal plane detector chips and infrared thermal imaging systems [32] Group 30 - Kangyuan Pharmaceutical's actual controller recently increased holdings by 20,000 shares [33] - The company specializes in the research, production, and sales of pharmaceuticals [33] Group 31 - Haida Group plans to repurchase shares worth between 1 billion and 1.6 billion yuan, with a maximum price of 62.00 yuan per share [34] - The company provides overall solutions for animal husbandry [34] Group 32 - Qizhong Technology's 850 million yuan convertible bonds have been approved for listing [35] - The company specializes in advanced packaging and testing of integrated circuits [35] Group 33 - Dingyang Technology launched the new SNA5000B series vector network analyzer [36] - The company specializes in the research, production, and sales of general electronic testing and measuring instruments [36] Group 34 - Airo Energy plans to distribute a cash dividend of 0.9375 yuan per share to all shareholders [37] - The company specializes in photovoltaic energy storage systems and products [37] Group 35 - Hechuan Technology's actual controller and some directors plan to reduce holdings by up to 6% of the company's shares [38] - The company specializes in the research, production, and sales of industrial automation products [38] Group 36 - China First Heavy Industries' chairman was arrested for suspected bribery [39] - The company specializes in heavy machinery manufacturing for various industries [39] Group 37 - Lianhuan Pharmaceutical plans to invest 15 million yuan in joint research with Nanjing University for anti-thrombotic small nucleic acid drugs [40] - The company specializes in the manufacturing and sales of chemical raw materials [40] Group 38 - Anxu Biotech's shareholder plans to reduce holdings by up to 0.94% of the company's shares, totaling no more than 120,000 shares [41] - The company specializes in the research, production, and sales of POCT reagents and instruments [41] Group 39 - Yaxiang Integration's shareholder reduced holdings by 130,000 shares [42] - The company specializes in providing cleanroom engineering and related services for high-tech electronic industries [42] Group 40 - Zhongwen Media plans to use up to 9.5 billion yuan of idle funds to purchase financial products [43] - The company specializes in traditional publishing and various new media businesses [43]